1. Home
  2. CHRS vs MNSB Comparison

CHRS vs MNSB Comparison

Compare CHRS & MNSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coherus BioSciences Inc.

CHRS

Coherus BioSciences Inc.

HOLD

Current Price

$1.29

Market Cap

177.7M

Sector

Health Care

ML Signal

HOLD

Logo MainStreet Bancshares Inc.

MNSB

MainStreet Bancshares Inc.

HOLD

Current Price

$25.10

Market Cap

164.1M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHRS
MNSB
Founded
2010
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
177.7M
164.1M
IPO Year
2014
2017

Fundamental Metrics

Financial Performance
Metric
CHRS
MNSB
Price
$1.29
$25.10
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$5.51
N/A
AVG Volume (30 Days)
898.4K
20.4K
Earning Date
05-07-2026
04-20-2026
Dividend Yield
N/A
1.68%
EPS Growth
472.00
210.00
EPS
N/A
1.05
Revenue
N/A
$135,615,000.00
Revenue This Year
$73.08
$1.50
Revenue Next Year
$30.94
$3.77
P/E Ratio
N/A
$23.50
Revenue Growth
N/A
N/A
52 Week Low
$1.09
$17.86
52 Week High
$2.62
$25.87

Technical Indicators

Market Signals
Indicator
CHRS
MNSB
Relative Strength Index (RSI) 48.85 47.89
Support Level $1.33 $24.36
Resistance Level $1.51 $25.16
Average True Range (ATR) 0.08 0.45
MACD -0.00 -0.11
Stochastic Oscillator 59.37 39.66

Price Performance

Historical Comparison
CHRS
MNSB

About CHRS Coherus BioSciences Inc.

Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its portfolio includes LOQTORZI which was developed for its ability to block PD-1 interactions with its ligands, PD-L1 and PD-L2, by binding to the FG loop on the PD-1 receptor. Company believe blocking PD-1 interactions with PD-L1 and PD-L2 can help to promote the immune systems.

About MNSB MainStreet Bancshares Inc.

MainStreet Bancshares Inc is a bank holding company. It is focused on serving the borrowing, cash management and depository needs of small to medium-sized businesses, and professional practices and retail customers. The bank's products and services include business and consumer checking, premium interest-bearing checking, business account analysis, savings, certificates of deposit and other depository services, as well as a broad array of commercial, real estate and consumer loans.

Share on Social Networks: